用抗生素组合治疗产生胆固醇依赖的Acinetobacter baumannii在抑制剂度下
Jeongwoo Jo1, Ji Young Lee2, Hongbaek Cho3
1Department of Microbiology, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
概括
在Acinetobacter baumannii中,可克服胆固醇的依赖性. 将胆固醇与其他抗生素 (如阿米卡) 结合起来,可以防止这种依赖性,为对抗多药耐药性感染提供了一种新的策略.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 胆固醇依赖性是对胆固醇敏感的Acinetobacter baumannii的一个常见挑战.
- 依赖胆固醇的突变体对其他抗生素的敏感性增加,这表明其具有治疗潜力.
- 耐多药性 (MDR) Acinetobacter baumannii构成重大威胁,需要新的治疗策略.
研究的目的:
- 调查结合其他抗生素对MDR Acinetobacter baumannii结合的胆固醇在体外和体内疗效.
- 为了确定组合疗法是否可以预防胆固醇依赖的发展.
- 评估消除依赖胆固醇素的突变体的治疗方案.
主要方法:
- 在实验室中进行了杀时测试和棋盘测试.
- 在体内有效性使用Galleria mellonella感染模型进行评估.
- 使用了MDR Acinetobacter baumannii表现出胆固醇依赖性的菌株.
主要成果:
- 结合胆固醇与抗生素的抑制度,特别是阿米卡辛,消除了MDR Acinetobacter baumannii菌株的结合.
- 组合疗法在体外抑制了胆固醇素依赖的发展.
- 在体内,素-抗生素组合显著提高了Galleria mellonella幼虫的存活率,而不是单独使用素.
结论:
- 联合治疗,特别是素与阿米卡辛,是对抗Acinetobacter baumannii感染的有希望的策略.
- 这种方法有效地消除了依赖素的突变体,并克服了耐药性.
- 进一步研究这些组合作为治疗选择是有必要的.
更多相关视频
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
656
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
4.7K
相关概念视频
Combined Effects of Drugs: Synergism
4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.1K
Antibiotic Selection
54.8K
Overview
54.8K
Development of Antibiotic Resistance
46
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
46
Pulmonary Tuberculosis V
214
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
214
Acute Pyelonephritis II: Diagnostic Studies and Management
19
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
19
